Financials disclosed in this offering
FY2022–FY2023 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
2 amendments- Feb 26, 2025
- Deadline Apr 29, 2025 → Mar 7, 2025closing early
“Issuer is moving up end date to March 7th, 2025.”
Form C/A on EDGAR ↗ - Feb 10, 2025
- Deadline Mar 12, 2025 → Apr 29, 2025
- Target $124K → $20K
“Added disclosure of 4M shares tied to stock options. Clarified financial data sources, including preliminary 2024 info. Updated key loan terms, D&O time split, and related entities. Lowered min. funding goal, updated use of proceeds, extended offering.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
Perks
Offering details
Links & provenance
0001665160-24-001799
Last synced Aug 18, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.